JW Pharma takes gout drug Epaminurad to Malaysia for phase 3

JW Pharma takes gout drug Epaminurad to Malaysia for phase 3

South Korea's JW Pharmaceutical Corp., announced on Monday that it has received approval from the Malaysian National Pharmaceutical Regulatory Age...

JW Pharma to conduct Phase 3 trials in Thailand for gout treatment

JW Pharma to conduct Phase 3 trials in Thailand for gout treatment

South Korea's JW Pharmaceutical Corp. on Thursday said it received approval from Thailand's Food and Drug Administration to conduct Phase 3 clinical...

JW Pharma applies for phase 3 trial in Taiwan for gout treatment

JW Pharma applies for phase 3 trial in Taiwan for gout treatment

JW Pharmaceutical announced through its disclosure on Monday that it had applied last Friday for a phase 3 trial for Epaminurad, a gout treatment, w...

K-beauty boom propels APR ahead of LG H&H, closing gap with AmorePacific IMM joins $600 mn fund for K-beauty unicorn Goodai Global in M&A drive Blackpink’s Jump music video draws 100 mn YouTube views Seoul signals agricultural market access on tariff talks table amid intensifying US trade pressure Korea’s top four financial holding firms post stellar Q2 profit on won, non-interest gains
banner